International journal of clinical oncology
Efficacy and safety of subcutaneous mosunetuzumab in combination with lenalidomide and as a monotherapy in Japanese patients with relapsed/refractory follicular lymphoma.
Shinichi Makita, Koji Izutsu, Yuko Mishima, Takahiro Kumode, Junya Kuroda, Nobuhiro Kanemura, Noriko Fukuhara, Kazuyuki Shimada, Chiemi Mori, Atsuko Kawasaki, Takeshi Miyake, Dai Maruyama
Published: 202610.1007/s10147-025-02957-1
Abstract
BACKGROUND: JO40295 (jRCT2080223801) evaluated the efficacy and safety of subcutaneous (SC) mosunetuzumab, in combination with lenalidomide and as monotherapy, in Japanese patients with relapsed/refractory (R/R) follicular lymphoma (FL). We report ou…
Preview only. Read the full abstract at the source